The Institute for OneWorld Health

The Institute for OneWorld Health (iOWH) is a nonprofit pharmaceutical firm that develops safe, effective and affordable new medicines for people with infectious diseases in the developing world.  iOWH has registered its first drug in India for visceral leishmaniasis and has been expanding its portfolio of products to address other neglected diseases.

• Develop a five-year strategic brief to guide the organization's transition to a new CEO
• Develop a five-year strategic plan for the diarrheal diseases portfolio, including a prioritized set of target product profiles, a portfolio management strategy, an access and communications plan and a list of targeted donors
• Create a commercialization methodology for a new anti-secretory product for the treatment of diarrheal diseases in developing countries